PE Tech Report

NEWSLETTER

Like this article?

Sign up to our free newsletter

Inflexion invests in Upperton

Inflexion has made a substantial investment into Upperton Pharma Solutions (Upperton), a UK-based specialist contract development and manufacturing organisation (CDMO) which has expertise in particle engineering for the pharmaceutical industry.

Inflexion has invested alongside the founder and the management team who will continue to lead the business. 

The investment is being made from Inflexion Enterprise Fund V.

Nottingham-based Upperton was founded in 1999 and conducts formulation and analytical development and clinical trial manufacturing services for small to mid sized pharma clients.

Like this article? Sign up to our free newsletter

MOST POPULAR

FURTHER READING

Featured